medical / technology / education / art / flub
Biosimilar drugs could save up to $110 billion by 2020 - IMS : Lower-cost copies of complex biotech drugs, known as biosimilars, could save the United States and Europe's five top markets as much as 98 billion euros ($110 bln) by 2020, a new analysis showed on Tuesday.
Source: uk.reuters.com